Elizabeth Colston

Immune Checkpoint Inhibition in Sepsis: A Phase 1b Randomized, Placebo-Controlled, Single Ascending Dose Study of Antiprogrammed Cell Death-Ligand 1 Antibody (BMS-936559)*

Richard S. Hotchkiss, Elizabeth Colston, Sachin Yende et al. · Critical Care Medicine · 2019 · 222 citations · Full text

Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab

Richard S. Hotchkiss, Elizabeth Colston, Sachin Yende et al. · Intensive Care Medicine · 2019 · 177 citations · Full text

Inflammation, Phase 1B, Immunology +6

Soluble receptor-resistant poliovirus mutants identify surface and internal capsid residues that control interaction with the cell receptor.

Elizabeth Colston, Vincent R. Racaniello · The EMBO Journal · 1994 · 100 citations · Full text

Virus Structure, Internal Capsid Residues, Pathogenesis +8

Poliovirus variants selected on mutant receptor-expressing cells identify capsid residues that expand receptor recognition

Elizabeth Colston, Vincent R. Racaniello · Journal of Virology · 1995 · 74 citations · Full text

Synthetic Virology, Poliovirus Host Range, Immunology +18

Deucravacitinib in moderate‐to‐severe plaque psoriasis: Pooled safety and tolerability over 52 weeks from two phase 3 trials (<scp>POETYK PSO</scp>‐1 and <scp>PSO</scp>‐2)

Bruce Strober, Andrew Blauvelt, Richard B. Warren et al. · Journal of the European Academy of Dermatology and Venereology · 2024 · 39 citations · Full text